GlassScriptPhysician profile
Christina T Bach
NPI 1396164174
$53,424.52
in general payments reported to CMS, 2019-2025
16 companies · $27K in 2025
The $27K reported for 2025 was more than what 96% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $133 · 2022: $1,591 · 2023: $10K · 2024: $15K · 2025: $27K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $47K · Food and Beverage: $3,449 · Travel and Lodging: $1,110 · Gift: $17.21.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $47,125.00 |
| Food and Beverage | $3,449.00 |
| Travel and Lodging | $1,110.13 |
| Gift | $17.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $52,271.37 | 2021-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Astrazeneca Pharmaceuticals LP | $295.49 | 2023-2025 | Airsupra, Fasenra, Breztri |
| Amgen INC. | $158.53 | 2024-2025 | Tezspire |
| Actelion Pharmaceuticals US, INC. | $108.75 | 2024-2025 | Uptravi, Opsumit |
| Genzyme Corporation | $93.51 | 2022-2025 | |
| Grifols USA, LLC | $90.89 | 2025 | Prolastin-C Liquid |
| Takeda Pharmaceuticals U.S.A., INC. | $73.01 | 2023-2024 | Glassia |
| Electromed, INC. | $71.31 | 2025 | Smartvest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $69.37 | 2023-2025 | Ofev, Stiolto Respimat, Spiriva Respimat |
| Fisher & Paykel Healthcare INC | $60.96 | 2024-2025 | Fisher & Paykel Healthcare |
| Baxter Healthcare | $31.13 | 2025 | Hillrom - Vest System Model 105 Home Care |
| Inspire Medical Systems, INC. | $25.05 | 2023 | Inspire |
| Insmed, INC. | $20.83 | 2025 | Brinsupri, Arikayce |
| 3b Medical, INC. | $19.98 | 2025 | Luna |
| Ethicon INC. | $19.05 | 2025 | Monarch Platform |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $15.29 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christina Bach listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.